FK960, a novel potential anti-dementia drug, enhances high K+-evoked release of somatostatin from rat hippocampal slices

Brain Research

Volumn 892, Issue 1, 2001, Pages 111-117

  Inoue, Tatsuo ^a   Wang, Feng ^a   Moriguchi, Akira ^a   Shirakawa, Kiyoharu ^a   Matsuoka, Nobuya ^a   Goto, Toshio ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Anti dementia; FK960; Hippocampus; Somatostatin; Transmitter release

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DEXTRO ASPARTIC ACID; N (4 ACETYL 1 PIPERAZINYL) 4 FLUOROBENZAMIDE; NOOTROPIC AGENT; PIPERAZINE DERIVATIVE; POTASSIUM; SEROTONIN; SOMATOSTATIN;

AMNESIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HIPPOCAMPUS; LONG TERM POTENTIATION; MOSSY FIBER; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

ACETYLCHOLINE; ANIMALS; ASPARTIC ACID; BENZAMIDES; DEMENTIA; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; NOOTROPIC AGENTS; PIPERAZINES; POTASSIUM; RATS; RATS, INBRED F344; SEROTONIN; SOMATOSTATIN; STEREOISOMERISM;

EID: 0035895829     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)03241-8     Document Type: Article

References (43)

1. 2+ currents in rod and cone photoreceptors of the salamander retina
2. Somatostatin and cognitive functions in Alzheimer's disease-the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine
3. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus
4. Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?
5. CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis
6. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors
7. Receptors controlling transmitter release from sympathetic neurons in vitro
8. Somatostatin release from rat cerebral cortex synaptosomes
9. B antagonist endowed with cognition enhancing activity
10. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on Vibratome sections: Coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia
11. Alzheimer's disease: A disorder of cortical cholinergic innervation
12. Selective loss of central cholinergic neurons in Alzheimer's disease
13. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia
14. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease
15. Correlations between water maze performance and cortical somatostatin mRNA and high-affinity binding sites during ageing in rats
16. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons
17. Role of glutamate receptor subtypes in the differential release of somatostatin, neuropeptideY, and substance P in primary serum-free cultures of striatal neurons
18. Pharmacological discrimination between γ-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes
19. Neuropeptide release by efficient recruitment of diffusing cytoplasmic secretory vesicles
20. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic
21. Molecular pharmacology of somatostatin receptors
22. The differential release of amino acids and neuropeptides from purified subpopulations of Mammalian GABAergic and cholinergic cerebrocortical synaptosomes
23. Roles of glutamate receptors in long-term potentiation at hippocampal mossy fiber synapses
24. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat
25. Activity-dependent neurotransmitter release kinetics: Correlation with changes in morphological distributions of small and large vesicles in central nerve terminals
26. A screening concept based on a hypothesis led to the development of a putative cognitive enhancer that stimulates penile erection
27. Somatostatin augments long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices
28. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task
29. Changes in brain somatostatin in memory deficient rats: Comparison with cholinergic markers
30. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: Comparison with physostigmine
31. FK960, a novel potential anti-dementia drug, augments long-term potentiation in mossy fiber-CA3 pathway of guinea-pig hippocampal slices
32. 3H] aspartate and endogenous L-aspartate and L-glutamate from rat cerebrocortical minislices
33. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
34. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
35. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine
36. Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material
37. Somatostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamus slices
38. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain
39. Exocytosis from large dense cored vesicles as a mechanism for neuropeptide release in the peripheral and central nervous system
40. Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats
41. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals
42. Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats
43. FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action